-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Aytu BioPharma (NASDAQ:AYTU) shares rose 45.0% to $2.64 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.7 million. The company's, Q1 earnings came out yesterday.
  • Marker Therapeutics (NASDAQ:MRKR) stock increased by 30.34% to $1.08. The company's market cap stands at $13.8 million. The company's, Q3 earnings came out yesterday.
  • Basel Medical Group (NASDAQ:BMGL) shares increased by 25.8% to $0.38. The company's market cap stands at $4.1 million.
  • Akanda (NASDAQ:AKAN) shares moved upwards by 15.85% to $2.56. The market value of their outstanding shares is at $5.8 million.
  • CEL-SCI (AMEX:CVM) stock rose 13.25% to $1.88. The company's market cap stands at $29.1 million.
  • NeOnc Technologies Hldgs (NASDAQ:NTHI) shares increased by 12.77% to $5.12. The market value of their outstanding shares is at $130.9 million.

Losers

  • SS Innovations Intl (NASDAQ:SSII) shares declined by 14.1% to $1.16 during Tuesday's pre-market session. The market value of their outstanding shares is at $270.6 million.
  • Baird Medical Investment (NASDAQ:BDMD) shares declined by 12.77% to $0.09. The market value of their outstanding shares is at $3.4 million.
  • XORTX Therapeutics (NASDAQ:XRTX) stock decreased by 12.67% to $0.91. The market value of their outstanding shares is at $2.3 million. As per the news, the Q3 earnings report came out yesterday.
  • Insight Molecular (NASDAQ:IMDX) stock fell 11.3% to $1.65. The company's market cap stands at $60.8 million. As per the press release, Q3 earnings came out yesterday.
  • Xtant Medical Holdings (AMEX:XTNT) stock decreased by 9.44% to $0.19. The company's market cap stands at $29.4 million. The company's, Q3 earnings came out yesterday.
  • NewcelX (NASDAQ:NCEL) stock fell 8.37% to $2.52. The company's market cap stands at $15.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending